Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HISTIOCYTIC MEDULLARY RETICULOSIS: A CASE REPORT

J HIRSH, B UNGAR, W E KING

    Australasian Annals of Medicine
    |August 1, 1964
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    BLOOD CELL COUNTBLOOD PLATELETSBONE MARROW CELLSCYCLOPHOSPHAMIDEDRUG THERAPYENZYME TESTSHEMOGLOBINOMETRYPATHOLOGYRETICULOENDOTHELIOSISSPLENECTOMY

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-tumour necrosis factor.

    Alimentary pharmacology & therapeutics·2018
    Same author

    Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.

    Alimentary pharmacology & therapeutics·2017
    Same author

    Re-phrasing the question: A simple tool for evaluation of adherence to therapy in patients with inflammatory bowel disease.

    United European gastroenterology journal·2017
    Same author

    Dust mite induces multiple polar T cell axes in human skin.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
    Same author

    Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Authors' reply.

    Alimentary pharmacology & therapeutics·2017
    Same author

    Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.

    Alimentary pharmacology & therapeutics·2016